BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9925521)

  • 1. Electrolytic generation of oxygen partially explains electrical enhancement of tobramycin efficacy against Pseudomonas aeruginosa biofilm.
    Stewart PS; Wattanakaroon W; Goodrum L; Fortun SM; McLeod BR
    Antimicrob Agents Chemother; 1999 Feb; 43(2):292-6. PubMed ID: 9925521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of electrical currents and tobramycin on Pseudomonas aeruginosa biofilms.
    Jass J; Costerton JW; Lappin-Scott HM
    J Ind Microbiol; 1995 Sep; 15(3):234-42. PubMed ID: 8519482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorate Specifically Targets Oxidant-Starved, Antibiotic-Tolerant Populations of Pseudomonas aeruginosa Biofilms.
    Spero MA; Newman DK
    mBio; 2018 Sep; 9(5):. PubMed ID: 30254119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin.
    Walters MC; Roe F; Bugnicourt A; Franklin MJ; Stewart PS
    Antimicrob Agents Chemother; 2003 Jan; 47(1):317-23. PubMed ID: 12499208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
    Garo E; Eldridge GR; Goering MG; DeLancey Pulcini E; Hamilton MA; Costerton JW; James GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sound waves effectively assist tobramycin in elimination of Pseudomonas aeruginosa biofilms in vitro.
    Bandara HM; Harb A; Kolacny D; Martins P; Smyth HD
    AAPS PharmSciTech; 2014 Dec; 15(6):1644-54. PubMed ID: 25155975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin.
    Müller L; Murgia X; Siebenbürger L; Börger C; Schwarzkopf K; Sewald K; Häussler S; Braun A; Lehr CM; Hittinger M; Wronski S
    J Antimicrob Chemother; 2018 Oct; 73(10):2762-2769. PubMed ID: 29982453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria.
    Costerton JW; Ellis B; Lam K; Johnson F; Khoury AE
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2803-9. PubMed ID: 7695266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin.
    Coquet L; Junter GA; Jouenne T
    J Antimicrob Chemother; 1998 Dec; 42(6):755-60. PubMed ID: 10052899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical enhancement of Streptococcus gordonii biofilm killing by gentamicin.
    Wattanakaroon W; Stewart PS
    Arch Oral Biol; 2000 Feb; 45(2):167-71. PubMed ID: 10716621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct electric current treatment under physiologic saline conditions kills Staphylococcus epidermidis biofilms via electrolytic generation of hypochlorous acid.
    Sandvik EL; McLeod BR; Parker AE; Stewart PS
    PLoS One; 2013; 8(2):e55118. PubMed ID: 23390518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 13. Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing
    Müsken M; Pawar V; Schwebs T; Bähre H; Felgner S; Weiss S; Häussler S
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR; White A; Elborn JS; Tunney MM
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections.
    Rojo-Molinero E; Macià MD; Rubio R; Moyà B; Cabot G; López-Causapé C; Pérez JL; Cantón R; Oliver A
    Antimicrob Agents Chemother; 2016 May; 60(5):2912-22. PubMed ID: 26926631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa.
    Barraud N; Hassett DJ; Hwang SH; Rice SA; Kjelleberg S; Webb JS
    J Bacteriol; 2006 Nov; 188(21):7344-53. PubMed ID: 17050922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model.
    Cao B; Christophersen L; Thomsen K; Sønderholm M; Bjarnsholt T; Jensen PØ; Høiby N; Moser C
    J Antimicrob Chemother; 2015 Jul; 70(7):2057-63. PubMed ID: 25786481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin.
    Eckert R; Brady KM; Greenberg EP; Qi F; Yarbrough DK; He J; McHardy I; Anderson MH; Shi W
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3833-8. PubMed ID: 16940063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms.
    Habash MB; Goodyear MC; Park AJ; Surette MD; Vis EC; Harris RJ; Khursigara CM
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
    Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.